Correlation Between Canon Inc and Olema Pharmaceuticals

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Canon Inc and Olema Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Canon Inc and Olema Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Canon Inc F and Olema Pharmaceuticals, you can compare the effects of market volatilities on Canon Inc and Olema Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Canon Inc with a short position of Olema Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Canon Inc and Olema Pharmaceuticals.

Diversification Opportunities for Canon Inc and Olema Pharmaceuticals

0.23
  Correlation Coefficient

Modest diversification

The 3 months correlation between Canon and Olema is 0.23. Overlapping area represents the amount of risk that can be diversified away by holding Canon Inc F and Olema Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Olema Pharmaceuticals and Canon Inc is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Canon Inc F are associated (or correlated) with Olema Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Olema Pharmaceuticals has no effect on the direction of Canon Inc i.e., Canon Inc and Olema Pharmaceuticals go up and down completely randomly.

Pair Corralation between Canon Inc and Olema Pharmaceuticals

Assuming the 90 days horizon Canon Inc F is expected to under-perform the Olema Pharmaceuticals. But the otc stock apears to be less risky and, when comparing its historical volatility, Canon Inc F is 2.96 times less risky than Olema Pharmaceuticals. The otc stock trades about -0.1 of its potential returns per unit of risk. The Olema Pharmaceuticals is currently generating about 0.04 of returns per unit of risk over similar time horizon. If you would invest  276.00  in Olema Pharmaceuticals on August 31, 2022 and sell it today you would earn a total of  6.00  from holding Olema Pharmaceuticals or generate 2.17% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Canon Inc F  vs.  Olema Pharmaceuticals

 Performance (%) 
       Timeline  
Canon Inc F 
Canon Performance
0 of 100
Over the last 90 days Canon Inc F has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest unfluctuating performance, the Stock's technical and fundamental indicators remain sound and the latest tumult on Wall Street may also be a sign of longer-term gains for the firm shareholders.

Canon Price Channel

Olema Pharmaceuticals 
Olema Performance
0 of 100
Over the last 90 days Olema Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's primary indicators remain somewhat strong which may send shares a bit higher in December 2022. The current disturbance may also be a sign of long term up-swing for the company investors.

Olema Price Channel

Canon Inc and Olema Pharmaceuticals Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Canon Inc and Olema Pharmaceuticals

The main advantage of trading using opposite Canon Inc and Olema Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Canon Inc position performs unexpectedly, Olema Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Olema Pharmaceuticals will offset losses from the drop in Olema Pharmaceuticals' long position.
Canon Inc vs. Hp Inc
Canon Inc vs. NetApp Inc
Canon Inc vs. Western Digital Cp
Canon Inc vs. Seagate Technology Hldgs
The idea behind Canon Inc F and Olema Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Olema Pharmaceuticals vs. Siemens Ag ADR
Olema Pharmaceuticals vs. Regeneron Pharmaceuticals
Olema Pharmaceuticals vs. Vertex Pharmaceutic
Check out your portfolio center. Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Analyst Recommendations module to analyst recommendations and target price estimates broken down by several categories.

Other Complementary Tools

Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Go
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Go
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Go
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Go
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Go
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Go